Aura Biosciences Inc (AURA)

Aura Biosciences Inc Azioni (AURA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	15.92% 17.05	20.28	15.43	15.12	14.40
Operating Income/Loss	9.97% -22.31	-24.78	-20.49	-20.28	-19.44
Nonoperating Income/Loss	4.88% 2.653	2.789	1.976	1.977	1.978
Income/Loss From Continuing Operations Before Tax	10.61% -19.66	-21.99	-18.51	-18.30	-17.47
Income Tax Expense/Benefit	0.046	-	-	-	-
Income/Loss From Continuing Operations After Tax	10.96% -19.71	-22.13	-18.51	-18.30	-17.47
Net Income/Loss	10.96% -19.71	-22.13	-18.51	-18.30	-17.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,849% 49.45	1.6769	38.19	37.86	37.78
Diluted Average Shares	2,849% 49.45	1.6769	38.19	37.86	37.78
Basic Earnings Per Share	20.00% -0.40	-0.50	-0.48	-0.48	-0.46
Diluted Earnings Per Share	20.00% -0.40	-0.50	-0.48	-0.48	-0.46
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-